Data Availability
The data that support the findings of this study are available from the corresponding author upon reasonable request.
References
Sechi E, Cacciaguerra L, Chen JJ, Mariotto S, Fadda G, Dinoto A, Lopez-Chiriboga AS, Pittock SJ, Flanagan EP (2022) Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): a review of clinical and MRI features, diagnosis, and management. Front Neurol 13:885218. https://doi.org/10.3389/fneur.2022.885218
Wynford-Thomas R, Jacob A, Tomassini V (2019) Neurological update: MOG antibody disease. J Neurol 266:1280–1286. https://doi.org/10.1007/s00415-018-9122-2
Alromaihi M (2022) Acute hemorrhagic leukoencephalitis (AHLE): a comprehensive review on causes, symptoms, link with COVID-19, diagnosis, and treatment. Biomed Res Int 2022:6008375. https://doi.org/10.1155/2022/6008375
Lee HY, Chang KH, Kim JH, Na DG, Kwon BJ, Lee KW, Park SH (2005) Serial MR imaging findings of acute hemorrhagic leukoencephalitis: a case report. AJNR Am J Neuroradiol 26:1996–1999
Tenembaum S, Chitnis T, Ness J, Hahn JS, International Pediatric MSSG (2007) Acute disseminated encephalomyelitis. Neurology 68:S23-36. https://doi.org/10.1212/01.wnl.0000259404.51352.7f
Stone MJ, Hawkins CP (2007) A medical overview of encephalitis. Neuropsychol Rehabil 17:429–449. https://doi.org/10.1080/09602010601069430
Yamamoto N, Kuki I, Nagase S, Inoue T, Nukui M, Okazaki S, Kunihiro N, Uda T, Fukuoka M, Kubota J, Hamano SI, Sakuma H, Kawawaki H (2021) Subtotal hemispherotomy for late-onset spasms after anti-myelin oligodendrocyte glycoprotein antibody-positive acute haemorrhagic leukoencephalitis. Epileptic Disord 23:957–960. https://doi.org/10.1684/epd.2021.1347
Salama S, Khan M, Pardo S, Izbudak I, Levy M (2019) MOG antibody-associated encephalomyelitis/encephalitis. Mult Scler 25:1427–1433. https://doi.org/10.1177/1352458519837705
Lampros A, De Broucker T, Bonnan M (2021) Fever is a common onset feature of MOG-IgG associated disorders (MOGAD). Mult Scler Relat Disord 49:102748. https://doi.org/10.1016/j.msard.2021.102748
Kao HW, Alexandru D, Kim R, Yanni D, Hasso AN (2012) Value of susceptibility-weighted imaging in acute hemorrhagic leukoencephalitis. J Clin Neurosci 19:1740–1741. https://doi.org/10.1016/j.jocn.2011.04.034
Hardy TA, Reddel SW, Barnett MH, Palace J, Lucchinetti CF, Weinshenker BG (2016) Atypical inflammatory demyelinating syndromes of the CNS. Lancet Neurol 15:967–981. https://doi.org/10.1016/s1474-4422(16)30043-6
Patterson K, Iglesias E, Nasrallah M, Gonzalez-Alvarez V, Sunol M, Anton J, Saiz A, Lancaster E, Armangue T (2019) Anti-MOG encephalitis mimicking small vessel CNS vasculitis. Neurol Neuroimmunol Neuroinflamm 6:e538. https://doi.org/10.1212/NXI.0000000000000538
Baba T, Shinoda K, Watanabe M, Sadashima S, Matsuse D, Isobe N, Yamasaki R, Kaneko K, Takahashi T, Iwaki T, Kira JI (2019) MOG antibody disease manifesting as progressive cognitive deterioration and behavioral changes with primary central nervous system vasculitis. Mult Scler Relat Disord 30:48–50. https://doi.org/10.1016/j.msard.2019.01.053
Cao Y, Xu J, Yi Z, Zhou L (2023) A case of MOGAD complicated with cerebral vasculitis: case report and literature review. J Clin Neurol 19:96–98. https://doi.org/10.3988/jcn.2023.19.1.96
Marignier R, Hacohen Y, Cobo-Calvo A et al (2021) Myelin-oligodendrocyte glycoprotein antibody-associated disease. Lancet Neurol 20:762–772. https://doi.org/10.1016/s1474-4422(21)00218-0
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Ethical approval
None.
Informed consent
Informed consent for publication was obtained from the patient.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Bang, S.J., Kim, S. & Seok, H.Y. Acute hemorrhagic leukoencephalitis as a new phenotype of myelin oligodendrocyte glycoprotein antibody-associated disease. Neurol Sci 44, 3741–3743 (2023). https://doi.org/10.1007/s10072-023-06847-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-023-06847-0